As demand for weight-loss drugs rises, states grapple with Medicaid coverage Thirteen states cover GLP-1 drugs through their Medicaid programs, and others are considering following suit (Mario Tama/Getty Images)
Patient data for the study was provided by the US National Institutes of Health All of Us Research Program, one of the largest and most diverse health databases in the USA
Wegovy Lawsuit Updates From 2025 December 22, 2025: New, Cheaper Version of Semaglutide Is Approved in Canada While Wegovy Lawsuits Continue in US Canadas authorities have approved Novo Nordisks request to sell Plosbrio, a bio-equivalent version of its blockbuster Wegovy weight loss injection
Gamage, N
29 This period should be viewed not just as a time for the medication to induce weight loss, but as an active learning phase
Originally intended for the treatment of type 2 diabetes, clinical trials found that they are also able to treat obesity by significantly decreasing a patients appetite